SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

Wendelin Moser; Mohammed Ahmed Hassan Fahal; Elamin Abualas; Shahinaz Bedri; Mahgoub Taj Elsir; Mona Fateh El Rahman Omer Mohamed; Abdelhalim Babiker Mahmoud; Amna Ismail Ibrahim Ahmad; Mohammed A. Adam; Sami Altalib; Ola Adil DafaAllah; Salahaldin Abdallah Hmed; Andrew S. Azman; Iza Ciglenecki; Etienne Gignoux; Alan González; Christine Mwongera; Manuel Albela Miranda

doi:10.3201/eid2805.211951

SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

Wendelin Moser, Mohammed Ahmed Hassan Fahal, Elamin Abualas, Shahinaz Bedri, Mahgoub Taj Elsir, Mona Fateh El Rahman Omer Mohamed, Abdelhalim Babiker Mahmoud, Amna Ismail Ibrahim Ahmad, Mohammed A. Adam, Sami Altalib, Ola Adil DafaAllah, Salahaldin Abdallah Hmed, Andrew S. Azman, Iza Ciglenecki, Etienne Gignoux, Alan González, Christine Mwongera, Manuel Albela Miranda

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

Abstract

In a cross-sectional survey in Omdurman, Sudan, during March–April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.

Original language	English (US)
Pages (from-to)	1026-1030
Number of pages	5
Journal	Emerging infectious diseases
Volume	28
Issue number	5
DOIs	https://doi.org/10.3201/eid2805.211951
State	Published - May 2022

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases
Epidemiology

Access to Document

10.3201/eid2805.211951

Cite this

Moser, W., Fahal, M. A. H., Abualas, E., Bedri, S., Elsir, M. T., Mohamed, M. F. E. R. O., Mahmoud, A. B., Ahmad, A. I. I., Adam, M. A., Altalib, S., DafaAllah, O. A., Hmed, S. A., Azman, A. S., Ciglenecki, I., Gignoux, E., González, A., Mwongera, C., & Miranda, M. A. (2022). SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan. Emerging infectious diseases, 28(5), 1026-1030. https://doi.org/10.3201/eid2805.211951

Moser, W, Fahal, MAH, Abualas, E, Bedri, S, Elsir, MT, Mohamed, MFERO, Mahmoud, AB, Ahmad, AII, Adam, MA, Altalib, S, DafaAllah, OA, Hmed, SA, Azman, AS, Ciglenecki, I, Gignoux, E, González, A, Mwongera, C & Miranda, MA 2022, 'SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan', Emerging infectious diseases, vol. 28, no. 5, pp. 1026-1030. https://doi.org/10.3201/eid2805.211951

@article{745e91959cb7486faeca659c60081d10,

title = "SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan",

abstract = "In a cross-sectional survey in Omdurman, Sudan, during March–April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.",

author = "Wendelin Moser and Fahal, {Mohammed Ahmed Hassan} and Elamin Abualas and Shahinaz Bedri and Elsir, {Mahgoub Taj} and Mohamed, {Mona Fateh El Rahman Omer} and Mahmoud, {Abdelhalim Babiker} and Ahmad, {Amna Ismail Ibrahim} and Adam, {Mohammed A.} and Sami Altalib and DafaAllah, {Ola Adil} and Hmed, {Salahaldin Abdallah} and Azman, {Andrew S.} and Iza Ciglenecki and Etienne Gignoux and Alan Gonz{\'a}lez and Christine Mwongera and Miranda, {Manuel Albela}",

note = "Funding Information: We thank all people participating in the survey, the survey surveyors for their hard work in the field, the laboratory technicians from the National Public Health Laboratory for the ELISA analysis, the team of the Innovation, Development and Research Directorate of the State Ministry of Health for their support, and Tania Kapoor for editorial support. We thank the National Public Health Laboratory, Sudan, for donating 5,000 rapid tests for the survey with kind permission from the Africa Centre for Disease Control Med{\'e}cins Sans Fronti{\`e}res–Switzerland (MSF–CH) funded the study, except for the tests donated by Africa CDC through the National Public Health Laboratory. Publisher Copyright: {\textcopyright} 2022 Centers for Disease Control and Prevention (CDC). All rights reserved.",

year = "2022",

month = may,

doi = "10.3201/eid2805.211951",

language = "English (US)",

volume = "28",

pages = "1026--1030",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "5",

}

TY - JOUR

T1 - SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

AU - Moser, Wendelin

AU - Fahal, Mohammed Ahmed Hassan

AU - Abualas, Elamin

AU - Bedri, Shahinaz

AU - Elsir, Mahgoub Taj

AU - Mohamed, Mona Fateh El Rahman Omer

AU - Mahmoud, Abdelhalim Babiker

AU - Ahmad, Amna Ismail Ibrahim

AU - Adam, Mohammed A.

AU - Altalib, Sami

AU - DafaAllah, Ola Adil

AU - Hmed, Salahaldin Abdallah

AU - Azman, Andrew S.

AU - Ciglenecki, Iza

AU - Gignoux, Etienne

AU - González, Alan

AU - Mwongera, Christine

AU - Miranda, Manuel Albela

N1 - Funding Information: We thank all people participating in the survey, the survey surveyors for their hard work in the field, the laboratory technicians from the National Public Health Laboratory for the ELISA analysis, the team of the Innovation, Development and Research Directorate of the State Ministry of Health for their support, and Tania Kapoor for editorial support. We thank the National Public Health Laboratory, Sudan, for donating 5,000 rapid tests for the survey with kind permission from the Africa Centre for Disease Control Medécins Sans Frontières–Switzerland (MSF–CH) funded the study, except for the tests donated by Africa CDC through the National Public Health Laboratory. Publisher Copyright: © 2022 Centers for Disease Control and Prevention (CDC). All rights reserved.

PY - 2022/5

Y1 - 2022/5

N2 - In a cross-sectional survey in Omdurman, Sudan, during March–April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.

AB - In a cross-sectional survey in Omdurman, Sudan, during March–April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.

UR - http://www.scopus.com/inward/record.url?scp=85128643474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128643474&partnerID=8YFLogxK

U2 - 10.3201/eid2805.211951

DO - 10.3201/eid2805.211951

M3 - Article

C2 - 35450565

AN - SCOPUS:85128643474

SN - 1080-6040

VL - 28

SP - 1026

EP - 1030

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 5

ER -

SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this